Evidence map›Paper›PMID 35350536›Full record

ArticleFrontiers in cardiovascular medicine2022

Pak2 Regulation of Nrf2 Serves as a Novel Signaling Nexus Linking ER Stress Response and Oxidative Stress in the Heart.

Pablo Binder, Binh Nguyen, Lucy Collins, Min Zi, Wei Liu, Foteini Christou, Xiaojing Luo, Susanne S Hille, Norbert Frey, Elizabeth J Cartwright and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. A Novel Pak1 Activator Ameliorates ER Stress for HFpEF Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Pathological implications of cellular stress in cardiovascular diseases.The international journal of biochemistry & cell biology · 2023
    Review
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Pablo BinderFaculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Binh NguyenFaculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Lucy CollinsFaculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Min ZiFaculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Wei LiuFaculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Foteini ChristouFaculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Xiaojing LuoInstitute of Pharmacology and Toxicology, Faculty of Medicine Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany.
Susanne S HilleDepartment of Internal Medicine III, University of Kiel, Kiel, Germany.
Norbert FreyDepartment of Cardiology, Angiology and Pneumology, University of Heidelberg, Heidelberg, Germany.
Elizabeth J CartwrightFaculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Jonathan ChernoffCancer Biology Program, Fox Chase Cancer Center, Philadelphia, PA, United States.
Oliver J MüllerDepartment of Internal Medicine III, University of Kiel, Kiel, Germany.
Kaomei GuanInstitute of Pharmacology and Toxicology, Faculty of Medicine Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany.
Xin WangFaculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
University of Manchester · GBUniversity Hospital Carl Gustav Carus · DEChristian-Albrechts-Universität zu Kiel · DEFox Chase Cancer Center · USGerman Centre for Cardiovascular Research · DEHeidelberg University · DE

Funding

British Heart Foundation FS/15/16/31477British Heart Foundation FS/18/73/33973British Heart Foundation FS/19/39/34447British Heart Foundation FS/19/70/34650British Heart Foundation PG/09/052/27833British Heart Foundation PG/12/76/29852British Heart Foundation PG/14/70/31039British Heart Foundation PG/14/71/31063British Heart Foundation PG/17/31/32988British Heart Foundation PG/19/53/34499British Heart Foundation PG/19/66/34600
6 · The paper itself

Abstract

Endoplasmic Reticulum (ER) stress and oxidative stress have been highly implicated in the pathogenesis of cardiac hypertrophy and heart failure (HF). However, the mechanisms involved in the interplay between these processes in the heart are not fully understood. The present study sought to determine a causative link between Pak2-dependent UPR activation and oxidative stress

Indexed as

ER stressgene therapyheart failureoxidative stressproteostasisRAAS and oxidative stress

Identifiers

PMID35350536
PMCPMC8957820
OpenAlexW4220913223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.